Altimmune to present at upcoming h.c. wainwright investor conferences october 12-13, 2021

Gaithersburg, md., oct. 06, 2021 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that members of the management team will be presenting virtually at the following h.c. wainwright investor conferences:

ALT Ratings Summary

ALT Quant Ranking